EDITORIAL
Published on 23 Feb 2022
Editorial: Resistance to Medical Therapy in Pituitary Tumors
doi 10.3389/fendo.2022.861230
- 1,084 views
- 1 citation
- Frontiers in Endocrinology
- Pituitary Endocrinology
- Research Topics
- Resistance to Medical Therapy in Pituitary Tumors
Resistance to Medical Therapy in Pituitary Tumors
9,158
Total downloads
29k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
MINI REVIEW
Published on 12 Jan 2022
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms
doi 10.3389/fendo.2021.791633
- 4,803 views
- 9 citations
ORIGINAL RESEARCH
Published on 07 May 2021
Clinical and Radiological Predictors of Biochemical Response to First-Line Treatment With Somatostatin Receptor Ligands in Acromegaly: A Real-Life Perspective
doi 10.3389/fendo.2021.677919
- 3,037 views
- 18 citations
REVIEW
Published on 16 Mar 2021
Pasireotide in the Personalized Treatment of Acromegaly
doi 10.3389/fendo.2021.648411
- 7,086 views
- 34 citations
MINI REVIEW
Published on 15 Mar 2021
Epithelial–Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly
doi 10.3389/fendo.2021.646210
- 2,433 views
- 18 citations
ORIGINAL RESEARCH
Published on 16 Feb 2021
A Novel Mechanism Regulating Dopamine Receptor Type 2 Signal Transduction in Pituitary Tumoral Cells: The Role of cAMP/PKA-Induced Filamin A Phosphorylation
doi 10.3389/fendo.2020.611752
- 2,375 views
- 9 citations
ORIGINAL RESEARCH
Published on 04 Aug 2020
Clinical, Hormonal, and Neuroradiological Characteristics and Therapeutic Outcomes of Prolactinomas in Children and Adolescents at a Single Center
doi 10.3389/fendo.2020.00527
- 4,221 views
- 10 citations
Published in
Frontiers in Endocrinology
- Pituitary Endocrinology
Impact
- 29kTopic views
- 19kArticle views
- 9,158Article downloads